Emerging Detail
BLSM - BlossomHill Therapeutics, Inc.
SNF Emerging Watchlist(TM) tracks newly public companies positioned around emerging economic themes. Inclusion reflects SNF research interest and ongoing monitoring; it is not a recommendation to buy, sell, or hold a security.
Emerging Score
83 / 100
Confidence
93%
Band
Strong Emerging Profile
Last Reviewed
Oct 23, 2026
Primary Theme
Biotechnology / Health Innovation
Exchange
Nasdaq
Current Thesis
Growth / Traction
What Changed
Candidate to Candidate review completed.
Why It Matters
Growth / Traction
What The Market Is Pricing In
Market Confirmation currently scores 50/100 within the Emerging Score framework.
What Could Change The Narrative
Early-stage oncology execution and durability of response data
SNF Lens
Signal
Growth / Traction
Noise
Some evidence needs refresh context.
Confirmation
Market Confirmation 50/100
Risk
Early-stage oncology execution and durability of response data
Six-Family Scorecard
88
84
91
88
84
50
Key Risks
Early-stage oncology execution and durability of response data
Clinical safety, competitive intensity and cash burn
Evidence Quality
Active Evidence
6
Sources
5
Stale Evidence
1
Freshness
Mixed freshness
Review / Score History
Oct 23, 2026Thesis unchanged - Candidate unchanged
Oct 23, 2026Score 83 / Confidence 93 / Candidate
Oct 4, 2026Score 83 / Confidence 93 / Candidate
Sources